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Facioscapulohumeral muscular dystrophy (FSHD) is associated with contractions of the D4Z4 repeat in the sub-
telomere of chromosome 4q. Two allelic variants of chromosome 4q (4qA and 4qB) exist in the region distal to
D4Z4. Although both variants are almost equally frequent in the population, FSHD is associated exclusively with
the 4qA allele. We identiﬁed three families with FSHD in which each proband carries two FSHD-sized alleles and
is heterozygous for the 4qA/4qB polymorphism. Segregation analysis demonstrated that FSHD-sized 4qB alleles
are not associated with disease, since these were present in unaffected family members. Thus, in addition to a
contraction of D4Z4, additional cis-acting elements on 4qA may be required for the development of FSHD.
Alternatively, 4qB subtelomeres may contain elements that prevent FSHD pathogenesis.
Facioscapulohumeral muscular dystrophy (FSHD or
FSHD1A [MIM 158900]) is a progressivemyopathy that
is mainly characterized by an often-asymmetric wast-
ing and weakness of the facial, shoulder, and upper-arm
muscles. FSHD displays a large clinical variability in ex-
pression and progression and can also present with non-
muscular features like hearing impairment and subclin-
ical retinovasculopathy (Padberg 2004). In severe cases,
CNS symptoms such as mental retardation and epilep-
tic seizures can be present (Funakoshi et al. 1998; Miura
et al. 1998).
In the vast majority of patients, autosomal dominant
FSHD is associated with a contraction of the D4Z4 re-
peat in the subtelomere of chromosome 4q. The D4Z4
repeat normally consists of a polymorphic array of 11–
100 KpnI units, each 3.3 kb in size. In patients with
FSHD, the D4Z4 repeat is reduced to 1–10 units (Wij-
menga et al. 1992; van Deutekom et al. 1993). A rough
inverse relationship has been established between the
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severity and progression of the disease and the residual
D4Z4 repeat size (Lunt et al. 1995; Tawil et al. 1996).
A homologous and equally polymorphic repeat is pre-
sent on chromosome 10q, but contractions of this repeat
have not been associated with disease (Bakker et al.
1995; Lemmers et al. 2001; Zhang et al. 2001). More-
over, completely or partially translocated repeats have
been identiﬁed on chromosomes 4 and 10 in ∼20% of
the population (Lemmers et al. 1998; van Overveld et
al. 2000). Nevertheless, only small repeats on chromo-
some 4 have been reported in patients with FSHD.
The D4Z4 repeat can be visualized onEcoRI-HindIII–
double-digested DNA that has been hybridized with
probe p13E-11 (Wijmenga et al. 1992) after separation
by pulsed ﬁeld gel electrophoresis (PFGE). This probe
recognizes the D4F104S1 locus that lies just proximal
to D4Z4 on chromosomes 4 and 10. Thus, after hy-
bridization, four fragments will be visualized, two from
each chromosome. Small sequence variations between
chromosome 4–derived and chromosome 10–derived re-
peat units allow differentiation between both chro-
mosomes by the use of speciﬁc restriction enzymes:
chromosome 4–derived units are resistant to BlnI and
are sensitive to XapI, whereas chromosome 10–derived
units have the opposite characteristics (Deidda et al.
1996; Lemmers et al. 2001).
There is increasing evidence that the contraction of
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Figure 1 Schematic presentation of the telomeric regions of chromosome 10q26 and the two variants of chromosome 4q35, 4qA and
4qB. The region distal to D4S2463 shows 98% homology between chromosomes 10q and 4q, except for the region distal to D4Z4 on the 4qB
variant. Both 4q alleles are almost equally present in the population, but FSHD has been associated with only the 4qA variant. Chromosome
4–type D4Z4 repeats are depicted as blackened triangles, and the chromosome 10 D4Z4 repeats are shown as unblackened triangles. The
locations of the EcoRI (E) and HindIII (H) restriction sites adjacent to D4Z4 are shown, as well as probes p13E-11 (blackened box), 4qB
(blackened box), and 4qA (unblackened box). Chromosomal assignment depicted in ﬁgure 2G–2I makes use of the NotI restriction site (N)
proximal to the chromosome 4–speciﬁc probe B31 (unblackened box).
D4Z4 causes a local chromatin alteration as well as the
transcriptional deregulation of genes by cis- or trans-
acting mechanisms (Gabellini et al. 2002; Jiang et al.
2003; Masny et al. 2004). A change in local chromatin
conformation is corroborated by the observation that
FSHD alleles are hypomethylated at D4Z4 (van Over-
veld et al. 2003).
Apparently, a contraction of the D4Z4 repeat on chro-
mosome 4 is not sufﬁcient to cause disease, since FSHD
is uniquely associated with only one of the two variants
of 4qter. The two 4qter alleles (4qA and 4qB) differ by
sequence variations distal to D4Z4. Although both alleles
are almost equally common in the population, FSHD al-
leles are always of the 4qA type (Lemmers et al. 2002;
van Geel et al. 2002). Since, in the control population,
both alleles have an equal mitotic propensity to rearrange,
it was proposed that a functional difference between both
chromosome ends must explain the unique association of
FSHD with 4qA. However, since these studies were per-
formed using samples from anonymous blood donors, we
could not exclude the possibility that small D4Z4 repeats
on 4qB chromosomes are pathogenic. By studying three
families (∼1% of Dutch patients with FSHD) that were
ascertained by the unusual observation that all probands
were heterozygous for an FSHD-sized allele, we here pro-
vide strong evidence that 4qB chromosomes that carry
FSHD-sized D4Z4 repeats do not cause disease. The
probes used for detailed D4Z4 repeat analysis, as well as
their positions in the restriction map of chromosomes 4
and 10, are depicted in ﬁgure 1.
In the ﬁrst family (Rf215 [ﬁg. 2A]), the proband (III-
1) already had severe symptoms of FSHD at the age of
12 years. In addition, he presented with telecanthus, het-
erochromia iridis, and a white forelock, all features of
Waardenburg syndrome (WS) (DeStefano et al. 1998).
However, he had no hypertelorism. The father (II-1),
paternal grandfather (I-1), and paternal uncle all had a
slowly progressing form of FSHD; there was no history
of muscle disease in the family of the mother (II-2)
throughout three generations. Physical and neurological
examinations of the mother, the maternal uncle (II-3),
and the grandmother (I-4) were normal.
PFGE analysis of the proband (III-1) demonstrated the
presence of two BlnI-resistant D4Z4 repeats of 20 kb
and 26 kb. In addition, chromosome 10–derived alleles
of 70 kb and 145 kb were identiﬁed on the basis of their
sensitivity to BlnI (ﬁg. 2A).
The allelic origin of all D4Z4 fragments was deter-
mined on HindIII-digested DNA with the use of probes
4qA and 4qB. This showed that the 20-kb repeat was
located on a 4qA chromosome, whereas the 26-kb frag-
ment originated from a 4qB allele. As expected, both
chromosome 10 alleles hybridized with probe 4qA (ﬁg.
2D).
To identify the chromosomal origin of these fragments,
NotI-digested DNAwas hybridizedwith the chromosome
4–speciﬁc probe B31. The chromosome 4–speciﬁc probe
B31 recognized the terminal NotI fragment on which
D4Z4 resides; this yielded a fragment that was 185 kb
larger than the observed D4Z4-containingEcoRI-HindIII
fragment (Lemmers et al. 2003). Hybridization of probe
B31 with NotI-digested DNA of the proband yielded
chromosome 4–derived fragments of 205 kb (20 kb 
185 kb) and 211 kb (26 kb  185 kb) (ﬁg. 2G), which
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Figure 2 A–F, Southern blot analysis of samples from three families with FSHD (Rf215, Rf202, and Rf207). DNA was double-digested
with EcoRI-HindIII (E) and EcoRI-BlnI (B), separated by PFGE, and hybridized with probe p13E-11. The FSHD-sized 4qB alleles (unblackened
circles) of 26 kb, 30 kb, and 34 kb, respectively, are underlined (A–C). FSHD-causing 4qA alleles are indicated with blackened circles. For
allelotyping (4qA/4qB), DNA was digested with HindIII, separated by PFGE, and subsequently hybridized with probes 4qA and 4qB (D–F).
Marker sizes (in kb) are indicated on the right. A and D, In family Rf215, the affected proband (III-1) carried two chromosome 4–type FSHD-
sized D4Z4 repeats. Allelotyping shows that the 20-kb D4Z4 repeat is of 4qA origin and was inherited from the affected father. The 26-kb
D4Z4 repeat was inherited from the healthy mother and is of 4qB origin (D). Furthermore, the affected child carried chromosome 10 repeats
of 70 kb and 145 kb. Segregation analysis showed that the FSHD-causing allele was inherited from the affected grandfather (I-1) and that the
nonpathogenic short 4qB allele was inherited from the healthy maternal grandmother (I-4) and is also observed in a healthy uncle (II-3) of the
affected proband (III-1) (A). B and E, In family Rf202, three affected sisters (II-1, II-2, and II-3) were identiﬁed as carriers of two FSHD-sized
D4Z4 repeats. Allele-sizing and allelotyping identiﬁed a 25-kb 4qA allele and a 30-kb 4qB allele (B and E). The 30-kb 4qB allele was inherited
from the healthy father (I-1), and the FSHD-causing 25-kb 4qA allele was inherited from the affected mother (I-2). Comigrating chromosome
10 alleles of 75 kb in the father are marked with “*1.” The mother carried a 45-kb chromosome 4–type allele (marked with “*2”), which
originated from chromosome 10 (translocated chromosome 4–type repeat) and was passed to her daughters II-1 and II-3. C and F, In family
Rf207, the oldest affected daughter (II-1) carried two FSHD-sized repeats. Allele-sizing and allelotyping identiﬁed a 27-kb 4qA allele and a 34-
kb 4qB allele (C and F). The 34-kb 4qB allele was inherited from the healthy father (I-1), and the FSHD-causing 27-kb 4qA allele was inherited
from the affected mother (I-2). Further analyses show that the FSHD allele in the mother comigrates with a chromosome 10 allele of 27 kb
(marked with “*3”). G–I, Chromosome assignment of the D4Z4 repeats in three families with FSHD (Rf215, Rf202, and Rf207).NotI-digested
DNA plugs and the chromosome 4–speciﬁc probe B31 were used. The NotI fragment is 185 kb larger than the EcoRI-HindIII fragment on
chromosome 4. Marker sizes (in kb) are indicated on the right. G, The two chromosome 4–derived repeats of 20 kb and 26 kb in the compound
heterozygous affected proband (III-1) in family Rf215 are visualized at 205 kb (20 kb  185 kb) and 211 kb (26 kb  185 kb). These results
show that both FSHD-sized repeats do indeed reside on chromosome 4. Furthermore, the chromosomal assignment reveals that the chromosome
4–type 75-kb repeat in the father resides on chromosome 4 (75 kb  185 kb p 260 kb), just like the 200-kb repeat in the mother (200 kb 
185 kb p 385 kb). H, Chromosomal assignment in family Rf202 shows that the two FSHD-sized alleles inherited by the three affected sisters
(II-1, II-2, and II-3) are both located on chromosome 4. They are visualized at 210 kb (25 kb  185 kb) and 215 kb (30 kb  185 kb),
corresponding to the paternal 25-kb repeat and the maternal 30-kb repeat, respectively. The other chromosome 4 alleles from the father and
the mother are visualized at 281 kb (96 kb  185 kb) and 240 kb (55 kb  185 kb), respectively. I, The two FSHD-sized alleles in the affected
daughter (II-1) of family Rf207 are located on chromosome 4 and are visible at 212 kb (27 kb  185 kb) and 219 kb (34 kb  185 kb).
conﬁrmed the chromosome 4 origin of both of the FSHD-
sized D4Z4 repeats.
Segregation analysis demonstrated that the 20-kb 4qA
allele was also present in the affected family members.
Consequently, the 26-kb 4qB allele found in the proband
was inherited from his healthy mother (II-2). This allele
was also present in the unaffected grandmother (I-4) and
in the unaffected uncle (II-3) of the proband (ﬁg. 2A).
Since mutations in PAX3 have been associated with
WS and since the ﬁrst homeodomain of DUX4, a pu-
tative gene residing in each D4Z4 unit (Gabriels et al.
1999), is highly homologous to that of PAX3, we per-
formed a mutation analysis for PAX3 in the proband by
PCR ampliﬁcation of all protein-encoding exons, includ-
ing splice-donor and splice-acceptor sites, followed by di-
rect sequence analysis (Pandya et al. 1996). Nomutations
were detected in PAX3 (data not shown).
In the second family (Rf202 [ﬁg. 2B]), the proband (I-
2) had been identiﬁed as having FSHD at the age of 33
years. At the age of 63 years, she presented with typical
FSHD, includingmoderate, sometimes asymmetric,weak-
ness and wasting of the facial, shoulder girdle, and upper-
arm muscles. Her husband (I-1) was 64 years old and
presented no abnormalities on clinical and neurological
examination. All daughters (II-1, II-2, and II-3) showed
a slowly progressing form of FSHD, with mild-to-mod-
erate facial weakness, moderate-to-severe asymmetric
shoulder girdle weakness, andmoderate abdominalweak-
ness. All three siblings also suffered from common but
unrelated autoimmune diseases, including primary hy-
pothyroidism and hypoparathyroidism (II-1); chronic as-
peciﬁc respiratory affections and sarcoidosis (II-2); and
ulcerative colitis, sclerotic cholangitis, and activated pro-
tein C resistance (II-3).
PFGE analysis revealed that all three sisters carried
chromosome 4–derived D4Z4 repeats of 25 kb and 30
kb and a chromosome 10–derived D4Z4 repeat of 70 kb.
In addition, individual II-2 carried a chromosome10 allele
of 300 kb, whereas individuals II-1 and II-3 carried a
translocated chromosome 4–type D4Z4 repeat of 45 kb
on chromosome 10 (ﬁg. 2B).
Allelotyping performed using probes 4qA and 4qB
showed that the 25-kb chromosome 4–derived repeat re-
sides on 4qA, whereas the 30-kb repeat is located on a
4qB chromosome. The pathogenic 25-kb D4Z4 repeat
was also identiﬁed in other affected family members (data
not shown). The chromosome 10–derived repeats were
recognized by probe 4qA, and the translocated 45-kb
chromosome 4–derived repeat on chromosome 10 in in-
dividual I-2 was of 4qA origin (ﬁg. 2E). As expected, the
affected mother carried the 25-kb D4Z4 repeat on 4qA,
whereas the healthy father carried the 30-kb 4qB-derived
D4Z4 repeat.
After hybridization with probe B31, the chromosomal
assignment revealed NotI fragments of 210 kb (25 kb 
185 kb) and 215 kb (30 kb  185 kb) in all three sisters,
which conﬁrmed the presence of the 25-kb and 30-kb
D4Z4 fragments on chromosome 4 (ﬁg. 2H). In agree-
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ment with these ﬁndings, hybridization with probe p13E-
11 revealed the additional chromosome 10 fragments and
conﬁrmed that the 45-kb chromosome 4–like allele in
individuals I-2, II-1, and II-3 is translocated to chromo-
some 10 (data not shown).
Finally, in the third family (Rf207 [ﬁg. 2C]), the mother
(I-2) of the proband was identiﬁed as having FSHD at
the age of 49 years. She showed mild facial weakness,
moderate-to-severe shoulder girdle weakness, and bilat-
eral foot extensor weakness. Her husband had no symp-
toms or signs of FSHD at examination. Her oldest daugh-
ter (II-1) had a medical history of Klippel-Trenaunay-
Weber (KTW) syndrome and presented with mild facial
weakness and asymmetric weakness and atrophy of the
shoulder girdle and foot extensor muscles. The youngest
daughter (II-2) presented with mild facial and shoulder
paresis.
PFGE analysis revealed that patient II-1 carried the
familial FSHD allele of 27 kb, which, as expected, re-
sided on a 4qA chromosome. In addition, she carried a
chromosome 4–derived repeat of 34 kb of 4qB origin
and chromosome 10–derived repeats of 55 kb and 110
kb (ﬁg. 2F). Again, all chromosome assignments were
based on the sensitivity of the repeats for BlnI or XapI
and were conﬁrmed on NotI-digested DNA, which was
hybridized with probe B31 (ﬁg. 2C and 2I).
Patient II-1 inherited the disease allele from her af-
fected mother, who also carried a 4qB allele of 135 kb
and chromosome 10–derived repeats of 27 kb and 55
kb. Thus, the 34-kb repeat of 4qB origin was inherited
from the healthy father.
Heterozygosity or homozygosity for two FSHD-sized
D4Z4 alleles is very uncommon (∼1% in Dutch patients
with FSHD). Recently, we described two families inwhich
each proband was heterozygous for two D4Z4 repeats
!38 kb and presented with a typical FSHD phenotype
(Wohlgemuth et al. 2003). In addition, a patient was de-
scribed who was homozygous for an FSHD allele because
of consanguinity (Tonini et al. 2004a). All these alleles
were on a 4qA allele/chromosome, the subtelomeric var-
iant of 4q that is associated with the disease. It was
suggested that a dose effect of both alleles might aggra-
vate the disease, although this could not be conﬁrmed
in the homozygous patient.
In contrast to these patients, the heterozygous indi-
viduals reported here had one repeat that resided on a
4qA chromosome and another repeat that was located
on a 4qB chromosome. In these cases, the repeat that
comigrates with disease in these families resides on the
4qA chromosome, whereas the FSHD-sized repeat on
the 4qB chromosome is always inherited from a healthy
parent. Therefore, the presence of an FSHD-sized D4Z4
repeat on a 4qB chromosome in ﬁve healthy individuals
without any myopathic features strongly suggests that
contracted D4Z4 repeats on 4qB chromosomes are not
associated with FSHD. Formerly, we could not rule out
the possibility that D4Z4 repeats !38 kb on 4qB chro-
mosomes might be associated with disease, since these
data were derived from anonymous blood donors (Lem-
mers et al. 2002). However, in the present study, all 4qB
repeats are well within the FSHD size range, and, despite
the fact that nonpenetrance seems to be more prominent
in the upper size range of the D4Z4 repeat (Lunt 2000;
Tonini et al. 2004b), some myopathic features should
have been noted in these individuals if D4Z4 repeats
!38 kb on 4qB chromosomes cause FSHD. This non-
pathogeneity of short D4Z4 repeats on 4qB chromo-
somes may also explain the rare ﬁnding of FSHD-sized
D4Z4 repeats that do not cosegregate with disease in
families with unrelated neuromuscular disorders (Auer-
Grumbach et al. 2000).
It is interesting to note that all heterozygous patients
described here showed additional diseases that are nor-
mally not associated with FSHD. At present, it is unclear
whether or not these additional diseases are independent
of the heterozygosity for FSHD-sized alleles on chro-
mosomes 4qA and 4qB.
All three siblings in family Rf202 suffered from com-
mon but unrelated autoimmune diseases. A potential au-
toimmune mechanism in the muscle pathology of FSHD
has long been debated. In at least 40% of biopsies, in-
ﬂammatory inﬁltrations with a T-cell repertoire different
from that in patients with myositis or other muscular
dystrophies can be seen in the muscle of patients with
FSHD (Arahata et al. 1995). In addition, a few cases have
been reported in which the onset of FSHD seems to be
related to the onset of a viral infection or vaccination
(Tawil et al. 1993; Tupler et al. 1998).
The index patient in family Rf207 hadKTW syndrome.
KTW syndrome is commonly sporadic and might be a
genetic condition. Putative loci, including the recently dis-
covered susceptibility gene VG5Q (Tian et al. 2004), are
not related to the FSHD locus. Nevertheless, it is inter-
esting that both KTW syndrome and FSHD have been
suggested to be caused by a similar disease model in-
volving transcriptional derepression of essential disease
genes (Gabellini et al. 2004).
Patient III-1 in family Rf215 showed several features
common to WS, which is often caused by mutations in
the transcription factor PAX3 (Baldwin et al. 1992; Tas-
sabehji et al. 1992; DeStefano et al. 1998). Nevertheless,
we did not ﬁnd evidence of the presence of mutations
in the PAX3 gene in this patient, although the mutation
detection strategy does not exclude the presence of large
exonic deletions, intronic mutations, or mutations af-
fecting PAX3 gene transcription regulation. PAX3 and its
orthologue, PAX7, are involved in muscle differentiation
during embryogenesis and in adult muscle regeneration
(Buckingham et al. 2003), and their homeodomains are
closely related to the ﬁrst homeodomain of the FSHD
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candidate gene DUX4. Although expression analyses of
DUX4 have failed to identify its gene product, evidence
of the DUX4 protein was recently found in myoblast cul-
tures of patients with FSHD (Coppee et al. 2004). It is
tempting to speculate that ectopic expression of DUX4
may have caused this WS-like phenotype, but this hy-
pothesis cannot be pursued, since muscle biopsies from
this patient are currently unavailable.
This study demonstrates that D4Z4 repeats !38 kb that
reside on chromosome 4qB do not cause FSHD. There-
fore, in addition to a contraction of D4Z4, additional cis-
acting elements on 4qA may be required for the devel-
opment of FSHD. Alternatively, 4qB subtelomeres may
contain elements that prevent FSHD pathogenesis. Re-
gardless of the exact mechanism, this study demonstrates
that common subtelomeric polymorphisms can be of im-
portance to the development of human disease. Since large
variant alleles also exist for other chromosome ends
(Wilkie et al. 1991;Macina et al. 1994; Trask et al. 1998;
Mefford and Trask 2002), it will be interesting to study
their role in common diseases that are often associated
with subtelomeric rearrangements, such as idiopathic
mental retardation (Flint et al. 1995).
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